We identified the involvement of Bcl-2 family members in BTZ response, stemming from the observed increase in antiapoptotic Bcl-xL (encoded by BCL11A) and a decrease in proapoptotic Bax (encoded by BAX) at both gene and protein levels in acquired BTZ-resistant MCL cells. The gene discussed is CASC3; the disease is mantle cell lymphoma.